NEUROENDOCRINE TUMOR GEP GRADE 1-3

Clinical trials for NEUROENDOCRINE TUMOR GEP GRADE 1-3 explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE TUMOR GEP GRADE 1-3 trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE TUMOR GEP GRADE 1-3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Double attack on deadly tumors: radiation and chemo combo enters final testing

Disease control Recruiting now

This trial is testing if adding chemotherapy to a standard radiation treatment (called PRRT) works better for controlling aggressive neuroendocrine tumors in the gut or pancreas. It will enroll about 162 adults whose tumors show signs of being more active on a special scan (FDG P…

Matched conditions: NEUROENDOCRINE TUMOR GEP GRADE 1-3

Phase: PHASE3 • Sponsor: Tata Memorial Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

NEUROENDOCRINE TUMOR GEP GRADE 1-3

Get alerted when new NEUROENDOCRINE TUMOR GEP GRADE 1-3 trials appear

Double attack on deadly tumors: radiation and chemo combo enters final testing